Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hmga2
|
ENSMUSG00000056758.8 | high mobility group AT-hook 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_120474301_120474452 | Hmga2 | 1916 | 0.345326 | 0.33 | 1.4e-02 | Click! |
chr10_120475012_120475553 | Hmga2 | 1010 | 0.559149 | 0.32 | 1.8e-02 | Click! |
chr10_120475653_120475935 | Hmga2 | 498 | 0.808237 | 0.28 | 3.7e-02 | Click! |
chr10_120476388_120476612 | Hmga2 | 31 | 0.978819 | 0.24 | 7.6e-02 | Click! |
chr10_120474526_120474677 | Hmga2 | 1691 | 0.378738 | 0.20 | 1.5e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_16314412_16314574 | 20.98 |
Gm3148 |
predicted gene 3148 |
76866 |
0.1 |
chr10_92556536_92557110 | 18.36 |
Gm4800 |
predicted gene 4800 |
13153 |
0.16 |
chr13_107767262_107767617 | 15.20 |
Zswim6 |
zinc finger SWIM-type containing 6 |
19157 |
0.22 |
chr6_66399474_66399715 | 14.80 |
Gm44233 |
predicted gene, 44233 |
848 |
0.4 |
chr12_46075749_46076236 | 14.58 |
Gm24948 |
predicted gene, 24948 |
91649 |
0.09 |
chr9_92930312_92930463 | 13.69 |
Gm28054 |
predicted gene 28054 |
34555 |
0.17 |
chr4_32923442_32923826 | 13.47 |
Ankrd6 |
ankyrin repeat domain 6 |
129 |
0.96 |
chr13_29195836_29196009 | 13.06 |
Gm11364 |
predicted gene 11364 |
40698 |
0.19 |
chr1_81520769_81521201 | 12.87 |
Gm37210 |
predicted gene, 37210 |
1356 |
0.55 |
chr2_28296168_28296542 | 12.55 |
Gm13373 |
predicted gene 13373 |
27695 |
0.19 |
chr4_24019307_24019462 | 12.53 |
Gm28448 |
predicted gene 28448 |
85430 |
0.11 |
chr1_53740822_53740975 | 12.48 |
Stk17b |
serine/threonine kinase 17b (apoptosis-inducing) |
21795 |
0.18 |
chr3_115856880_115857079 | 12.24 |
Dph5 |
diphthamide biosynthesis 5 |
30858 |
0.11 |
chrX_93300120_93300496 | 11.74 |
Arx |
aristaless related homeobox |
13798 |
0.23 |
chr11_112501711_112502406 | 11.62 |
BC006965 |
cDNA sequence BC006965 |
167340 |
0.04 |
chr18_13798145_13798345 | 11.50 |
Zfp521 |
zinc finger protein 521 |
45587 |
0.19 |
chr15_89532343_89532628 | 11.43 |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
405 |
0.75 |
chr1_6800590_6800877 | 11.42 |
St18 |
suppression of tumorigenicity 18 |
2058 |
0.39 |
chr19_14776884_14777035 | 11.29 |
Gm26026 |
predicted gene, 26026 |
58479 |
0.15 |
chr2_106074528_106074752 | 11.28 |
Gm29053 |
predicted gene 29053 |
34144 |
0.14 |
chr2_30737839_30738040 | 11.28 |
Mir3089 |
microRNA 3089 |
16729 |
0.13 |
chr13_84065521_84065798 | 11.17 |
Gm17750 |
predicted gene, 17750 |
887 |
0.64 |
chr11_47459173_47459324 | 11.02 |
Sgcd |
sarcoglycan, delta (dystrophin-associated glycoprotein) |
79726 |
0.11 |
chr14_104902746_104902918 | 10.91 |
Gm24280 |
predicted gene, 24280 |
68595 |
0.12 |
chr3_153276935_153277086 | 10.90 |
1700012D16Rik |
RIKEN cDNA 1700012D16 gene |
21639 |
0.16 |
chr10_84822817_84823117 | 10.81 |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
11779 |
0.2 |
chr1_94503928_94504626 | 10.74 |
Gm7895 |
predicted gene 7895 |
34390 |
0.22 |
chr3_157321447_157321616 | 10.64 |
Gm22458 |
predicted gene, 22458 |
44467 |
0.14 |
chr12_58512843_58513053 | 10.51 |
Clec14a |
C-type lectin domain family 14, member a |
243658 |
0.02 |
chr15_57733279_57733651 | 10.51 |
9330154K18Rik |
RIKEN cDNA 9330154K18 gene |
5201 |
0.22 |
chr18_23038574_23038958 | 10.50 |
Nol4 |
nucleolar protein 4 |
110 |
0.98 |
chr2_144128059_144128224 | 10.46 |
Gm11687 |
predicted gene 11687 |
15232 |
0.16 |
chr13_83727942_83728228 | 10.41 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
21 |
0.96 |
chr15_13392917_13393530 | 10.37 |
Gm8238 |
predicted gene 8238 |
25633 |
0.22 |
chr1_41605098_41605443 | 10.30 |
Gm28634 |
predicted gene 28634 |
75727 |
0.12 |
chr13_83744413_83744884 | 10.27 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
5785 |
0.13 |
chr1_158547905_158548203 | 10.12 |
Gm37848 |
predicted gene, 37848 |
3912 |
0.17 |
chr1_162832603_162832910 | 10.03 |
Fmo1 |
flavin containing monooxygenase 1 |
1916 |
0.32 |
chr1_172617765_172617949 | 9.98 |
Dusp23 |
dual specificity phosphatase 23 |
15105 |
0.12 |
chr18_9216377_9216790 | 9.97 |
Fzd8 |
frizzled class receptor 8 |
4420 |
0.27 |
chr17_65742980_65743264 | 9.95 |
Rab31 |
RAB31, member RAS oncogene family |
29518 |
0.15 |
chr13_69260577_69260855 | 9.92 |
Gm4812 |
predicted gene 4812 |
84939 |
0.08 |
chr4_149220306_149220457 | 9.74 |
Kif1b |
kinesin family member 1B |
3137 |
0.22 |
chr19_18888764_18889099 | 9.74 |
Trpm6 |
transient receptor potential cation channel, subfamily M, member 6 |
48294 |
0.16 |
chr1_57330254_57330423 | 9.67 |
Gm5254 |
predicted gene 5254 |
37937 |
0.12 |
chr17_13668639_13669018 | 9.67 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
63 |
0.97 |
chr11_43270302_43270711 | 9.60 |
Gm12146 |
predicted gene 12146 |
10722 |
0.19 |
chr4_31727820_31728120 | 9.59 |
Map3k7 |
mitogen-activated protein kinase kinase kinase 7 |
236127 |
0.02 |
chr4_142638972_142639342 | 9.54 |
Gm37624 |
predicted gene, 37624 |
151651 |
0.04 |
chr6_22675181_22675332 | 9.35 |
Gm8927 |
predicted gene 8927 |
28180 |
0.16 |
chr3_127387010_127387518 | 9.35 |
Gm42969 |
predicted gene 42969 |
6442 |
0.16 |
chr4_148384621_148385111 | 9.30 |
Gm13200 |
predicted gene 13200 |
25406 |
0.13 |
chr1_94503474_94503673 | 9.29 |
Gm7895 |
predicted gene 7895 |
33686 |
0.23 |
chr3_82357392_82357703 | 9.27 |
Map9 |
microtubule-associated protein 9 |
497 |
0.88 |
chr14_24617943_24618207 | 9.06 |
4930428N03Rik |
RIKEN cDNA 4930428N03 gene |
507 |
0.52 |
chr4_154948580_154948853 | 9.05 |
Hes5 |
hes family bHLH transcription factor 5 |
12207 |
0.11 |
chr9_91228155_91228326 | 9.05 |
Gm29602 |
predicted gene 29602 |
12225 |
0.18 |
chr10_29143863_29144732 | 9.02 |
Gm9996 |
predicted gene 9996 |
103 |
0.69 |
chr16_44530336_44530771 | 8.93 |
Mir3081 |
microRNA 3081 |
27576 |
0.17 |
chr10_22659128_22659399 | 8.91 |
Slc2a12 |
solute carrier family 2 (facilitated glucose transporter), member 12 |
10255 |
0.19 |
chr13_77470252_77470403 | 8.90 |
Gm9634 |
predicted gene 9634 |
84046 |
0.1 |
chr18_23037418_23037876 | 8.89 |
Nol4 |
nucleolar protein 4 |
1009 |
0.7 |
chr16_86068018_86068384 | 8.89 |
Gm49570 |
predicted gene, 49570 |
52746 |
0.16 |
chr3_88206531_88206915 | 8.88 |
Gm3764 |
predicted gene 3764 |
90 |
0.91 |
chr11_96902762_96902935 | 8.83 |
Cdk5rap3 |
CDK5 regulatory subunit associated protein 3 |
5910 |
0.09 |
chr10_87489547_87489770 | 8.83 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
4002 |
0.23 |
chr18_47246485_47246927 | 8.81 |
Sema6a |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
34489 |
0.17 |
chr13_83750227_83750397 | 8.80 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
11449 |
0.12 |
chr11_113188158_113188571 | 8.72 |
2610035D17Rik |
RIKEN cDNA 2610035D17 gene |
13458 |
0.24 |
chr3_81661601_81661985 | 8.71 |
Gm43346 |
predicted gene 43346 |
59883 |
0.14 |
chr3_141197041_141197201 | 8.69 |
Pdha2 |
pyruvate dehydrogenase E1 alpha 2 |
15234 |
0.29 |
chr4_82946466_82946640 | 8.59 |
Frem1 |
Fras1 related extracellular matrix protein 1 |
5671 |
0.26 |
chr4_55929179_55929426 | 8.48 |
Gm12519 |
predicted gene 12519 |
64437 |
0.14 |
chr16_42276271_42276432 | 8.46 |
Gap43 |
growth associated protein 43 |
279 |
0.93 |
chr4_72167421_72167708 | 8.44 |
Gm11250 |
predicted gene 11250 |
1204 |
0.53 |
chr2_59351695_59352106 | 8.42 |
Pkp4 |
plakophilin 4 |
9703 |
0.19 |
chr10_87419886_87420133 | 8.41 |
Gm23191 |
predicted gene, 23191 |
55863 |
0.12 |
chr18_84232190_84232510 | 8.40 |
Gm50311 |
predicted gene, 50311 |
29426 |
0.2 |
chrX_143933301_143933468 | 8.37 |
Dcx |
doublecortin |
73 |
0.98 |
chr1_37098165_37098479 | 8.29 |
Vwa3b |
von Willebrand factor A domain containing 3B |
2209 |
0.32 |
chr8_87237253_87237404 | 8.21 |
Gm27169 |
predicted gene 27169 |
34302 |
0.15 |
chr7_13034968_13035352 | 8.20 |
Chmp2a |
charged multivesicular body protein 2A |
353 |
0.69 |
chr19_15340555_15340742 | 8.18 |
Gm24319 |
predicted gene, 24319 |
339356 |
0.01 |
chr14_93009566_93009910 | 8.18 |
Gm48963 |
predicted gene, 48963 |
117036 |
0.06 |
chr8_3493298_3493991 | 8.12 |
Zfp358 |
zinc finger protein 358 |
474 |
0.67 |
chrX_136992275_136992603 | 8.11 |
Slc25a53 |
solute carrier family 25, member 53 |
593 |
0.4 |
chr10_40762804_40762992 | 8.11 |
Mettl24 |
methyltransferase like 24 |
79616 |
0.08 |
chr2_154421078_154421682 | 8.06 |
Snta1 |
syntrophin, acidic 1 |
13281 |
0.16 |
chr4_48726548_48726699 | 8.04 |
Gm12438 |
predicted gene 12438 |
19227 |
0.17 |
chr10_125912420_125912571 | 8.03 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
53673 |
0.17 |
chr17_13479741_13479922 | 8.03 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
20505 |
0.11 |
chr12_27083107_27083496 | 8.02 |
Gm9866 |
predicted gene 9866 |
31694 |
0.24 |
chr2_137092072_137092235 | 7.97 |
Jag1 |
jagged 1 |
6204 |
0.3 |
chr9_71879542_71879779 | 7.93 |
Tcf12 |
transcription factor 12 |
5051 |
0.13 |
chr11_17658313_17658672 | 7.85 |
Gm12016 |
predicted gene 12016 |
19309 |
0.28 |
chrX_93429292_93429706 | 7.82 |
Pola1 |
polymerase (DNA directed), alpha 1 |
61447 |
0.12 |
chr12_12684730_12684971 | 7.80 |
Gm27952 |
predicted gene, 27952 |
2232 |
0.27 |
chr16_14361004_14362068 | 7.78 |
Abcc1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
22 |
0.97 |
chr12_46419651_46419841 | 7.77 |
Gm7422 |
predicted gene 7422 |
59581 |
0.14 |
chr8_112269600_112269769 | 7.77 |
Gm3635 |
predicted gene 3635 |
32718 |
0.22 |
chr13_78427761_78428104 | 7.75 |
Gm31946 |
predicted gene, 31946 |
684 |
0.71 |
chr7_78888072_78888248 | 7.72 |
Mir7-2 |
microRNA 7-2 |
117 |
0.94 |
chr18_42740241_42740444 | 7.69 |
C030004G16Rik |
RIKEN cDNA C030004G16 gene |
117883 |
0.05 |
chr6_50776382_50776589 | 7.68 |
C530044C16Rik |
RIKEN cDNA C530044C16 gene |
161 |
0.95 |
chr7_79543495_79543979 | 7.67 |
Gm35040 |
predicted gene, 35040 |
7694 |
0.09 |
chr1_171980417_171980750 | 7.61 |
Vangl2 |
VANGL planar cell polarity 2 |
28446 |
0.11 |
chr4_63459173_63459841 | 7.59 |
Whrn |
whirlin |
1795 |
0.32 |
chr1_6734649_6734817 | 7.51 |
St18 |
suppression of tumorigenicity 18 |
137 |
0.98 |
chr8_90741015_90741332 | 7.46 |
Gm35850 |
predicted gene, 35850 |
398 |
0.82 |
chr2_24664970_24665121 | 7.45 |
Gm13459 |
predicted gene 13459 |
9656 |
0.17 |
chr19_21789022_21789200 | 7.42 |
Cemip2 |
cell migration inducing hyaluronidase 2 |
10723 |
0.21 |
chr5_101524000_101524342 | 7.40 |
Gm43103 |
predicted gene 43103 |
17842 |
0.24 |
chr2_46666169_46666434 | 7.39 |
Gm25264 |
predicted gene, 25264 |
59218 |
0.16 |
chr2_41094225_41094401 | 7.32 |
Gm13460 |
predicted gene 13460 |
95456 |
0.09 |
chr3_49756286_49756437 | 7.30 |
Pcdh18 |
protocadherin 18 |
897 |
0.63 |
chr13_84758615_84758805 | 7.30 |
Gm26913 |
predicted gene, 26913 |
67769 |
0.13 |
chr2_107869402_107869555 | 7.29 |
Gm23439 |
predicted gene, 23439 |
17161 |
0.3 |
chr6_111730472_111730623 | 7.27 |
Gm22093 |
predicted gene, 22093 |
127295 |
0.06 |
chr2_129699849_129700017 | 7.27 |
Pdyn |
prodynorphin |
89 |
0.97 |
chr10_29213650_29213801 | 7.26 |
9330159F19Rik |
RIKEN cDNA 9330159F19 gene |
2020 |
0.29 |
chr6_55704195_55704346 | 7.26 |
Gm3279 |
predicted gene 3279 |
19699 |
0.21 |
chr7_94926687_94926859 | 7.25 |
Gm19761 |
predicted gene, 19761 |
324365 |
0.01 |
chr11_32158605_32158866 | 7.18 |
Gm12109 |
predicted gene 12109 |
26270 |
0.12 |
chr4_7642984_7643147 | 7.13 |
8430436N08Rik |
RIKEN cDNA 8430436N08 gene |
82377 |
0.1 |
chr2_70202586_70203174 | 7.07 |
Myo3b |
myosin IIIB |
106582 |
0.06 |
chr4_8381922_8382305 | 7.07 |
Gm37386 |
predicted gene, 37386 |
72134 |
0.1 |
chr12_95119304_95119472 | 7.05 |
Gm4808 |
predicted gene 4808 |
203706 |
0.03 |
chr2_74450179_74450389 | 7.03 |
Lnpk |
lunapark, ER junction formation factor |
82822 |
0.07 |
chr2_53502011_53502162 | 7.02 |
Gm13503 |
predicted gene 13503 |
49840 |
0.17 |
chr4_55015608_55015759 | 7.01 |
Zfp462 |
zinc finger protein 462 |
4203 |
0.3 |
chr6_28396927_28397109 | 7.01 |
Zfp800 |
zinc finger protein 800 |
987 |
0.45 |
chr2_116020415_116021057 | 6.98 |
Meis2 |
Meis homeobox 2 |
21310 |
0.19 |
chr9_42179185_42179358 | 6.97 |
4930546K05Rik |
RIKEN cDNA 4930546K05 gene |
29942 |
0.15 |
chr1_84155676_84155827 | 6.96 |
Gm18304 |
predicted gene, 18304 |
12437 |
0.21 |
chr8_46295121_46295289 | 6.94 |
Helt |
helt bHLH transcription factor |
534 |
0.63 |
chr4_10051710_10051873 | 6.92 |
Gm11835 |
predicted gene 11835 |
92437 |
0.08 |
chr6_142876249_142876582 | 6.92 |
St8sia1 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 |
6625 |
0.21 |
chr16_87567629_87567949 | 6.92 |
Map3k7cl |
Map3k7 C-terminal like |
14459 |
0.14 |
chr9_75683480_75683688 | 6.88 |
Scg3 |
secretogranin III |
3 |
0.97 |
chr15_69246284_69246511 | 6.88 |
4930573C08Rik |
RIKEN cDNA 4930573C08 gene |
11398 |
0.25 |
chr3_56357023_56357196 | 6.87 |
Gm25727 |
predicted gene, 25727 |
88303 |
0.09 |
chr12_10875269_10875443 | 6.84 |
Pgk1-rs7 |
phosphoglycerate kinase-1, related sequence-7 |
24884 |
0.23 |
chr11_57583351_57583694 | 6.82 |
Gm12243 |
predicted gene 12243 |
11010 |
0.18 |
chr6_22833658_22833979 | 6.77 |
Gm43629 |
predicted gene 43629 |
28489 |
0.15 |
chr6_13838224_13838886 | 6.77 |
Gpr85 |
G protein-coupled receptor 85 |
101 |
0.97 |
chr7_113132059_113132210 | 6.75 |
4930543E12Rik |
RIKEN cDNA 4930543E12 gene |
9881 |
0.2 |
chr1_137838327_137838702 | 6.74 |
Gm37293 |
predicted gene, 37293 |
26665 |
0.12 |
chrX_93300503_93300679 | 6.70 |
Arx |
aristaless related homeobox |
14081 |
0.23 |
chr16_77235959_77236165 | 6.70 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
255 |
0.94 |
chr8_14381522_14381725 | 6.63 |
Dlgap2 |
DLG associated protein 2 |
111 |
0.98 |
chr10_12725144_12725295 | 6.63 |
Utrn |
utrophin |
36357 |
0.19 |
chr13_34150091_34150271 | 6.59 |
Psmg4 |
proteasome (prosome, macropain) assembly chaperone 4 |
12783 |
0.11 |
chr8_10391264_10391418 | 6.58 |
Myo16 |
myosin XVI |
118769 |
0.06 |
chr3_50634809_50634962 | 6.57 |
Gm37199 |
predicted gene, 37199 |
6474 |
0.19 |
chr9_103443833_103443984 | 6.56 |
5830418P13Rik |
RIKEN cDNA 5830418P13 gene |
2532 |
0.17 |
chr1_132201295_132201446 | 6.55 |
Lemd1 |
LEM domain containing 1 |
407 |
0.75 |
chr1_177410886_177411037 | 6.54 |
Gm26801 |
predicted gene, 26801 |
18123 |
0.17 |
chr12_112333857_112334228 | 6.53 |
Gm38123 |
predicted gene, 38123 |
16025 |
0.19 |
chr8_49372835_49372999 | 6.52 |
4930555F03Rik |
RIKEN cDNA 4930555F03 gene |
2004 |
0.44 |
chr6_87993885_87994594 | 6.50 |
4933412L11Rik |
RIKEN cDNA 4933412L11 gene |
60 |
0.94 |
chr5_32713265_32714499 | 6.46 |
Gm43852 |
predicted gene 43852 |
106 |
0.94 |
chr2_62808741_62808892 | 6.43 |
Gm13569 |
predicted gene 13569 |
371 |
0.89 |
chr16_77685559_77685884 | 6.43 |
Gm37694 |
predicted gene, 37694 |
444 |
0.75 |
chr10_74387760_74387995 | 6.42 |
Pcdh15 |
protocadherin 15 |
2004 |
0.5 |
chr13_91039537_91039704 | 6.41 |
Atg10 |
autophagy related 10 |
85990 |
0.08 |
chrX_67821225_67821376 | 6.41 |
Rpl7a-ps13 |
ribosomal protein L7A, pseudogene 13 |
95056 |
0.07 |
chr4_8577454_8577829 | 6.40 |
Rab2a |
RAB2A, member RAS oncogene family |
41997 |
0.17 |
chr8_87667719_87667882 | 6.40 |
4933402J07Rik |
RIKEN cDNA 4933402J07 gene |
103947 |
0.06 |
chr1_46830172_46830391 | 6.38 |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
5618 |
0.22 |
chr1_42243884_42244284 | 6.37 |
Gm29664 |
predicted gene 29664 |
5389 |
0.2 |
chr14_16200927_16201541 | 6.34 |
Rpl31-ps3 |
ribosomal protein L31, pseudogene 3 |
23789 |
0.13 |
chr2_179767571_179767722 | 6.34 |
Cdh4 |
cadherin 4 |
9517 |
0.27 |
chr15_64831813_64831972 | 6.34 |
Gm21798 |
predicted gene, 21798 |
14198 |
0.27 |
chr10_87102060_87102211 | 6.31 |
1700113H08Rik |
RIKEN cDNA 1700113H08 gene |
44089 |
0.14 |
chr2_109692795_109692946 | 6.29 |
Bdnf |
brain derived neurotrophic factor |
157 |
0.96 |
chr9_37625246_37625717 | 6.28 |
Siae |
sialic acid acetylesterase |
3827 |
0.14 |
chr14_105676531_105676705 | 6.28 |
Gm10076 |
predicted gene 10076 |
5210 |
0.22 |
chr14_102205486_102205672 | 6.27 |
Gm22347 |
predicted gene, 22347 |
124082 |
0.06 |
chr3_94485980_94486131 | 6.27 |
Celf3 |
CUGBP, Elav-like family member 3 |
591 |
0.53 |
chr5_131775741_131775975 | 6.27 |
Gm42442 |
predicted gene 42442 |
77505 |
0.07 |
chr9_21953247_21953604 | 6.25 |
Swsap1 |
SWIM type zinc finger 7 associated protein 1 |
2330 |
0.14 |
chr11_54754283_54754711 | 6.22 |
Cdc42se2 |
CDC42 small effector 2 |
5842 |
0.15 |
chr18_62868650_62868901 | 6.22 |
Gm50128 |
predicted gene, 50128 |
53326 |
0.12 |
chr2_146300726_146300877 | 6.22 |
Gm14117 |
predicted gene 14117 |
4746 |
0.23 |
chr9_15238712_15238977 | 6.21 |
Vstm5 |
V-set and transmembrane domain containing 5 |
201 |
0.88 |
chr8_10153565_10153926 | 6.19 |
Myo16 |
myosin XVI |
166 |
0.97 |
chr1_18308203_18308365 | 6.16 |
Defb41 |
defensin beta 41 |
43146 |
0.14 |
chr6_97616261_97616412 | 6.15 |
Frmd4b |
FERM domain containing 4B |
1193 |
0.5 |
chr6_33712610_33712773 | 6.14 |
Exoc4 |
exocyst complex component 4 |
11257 |
0.24 |
chr18_72725028_72725395 | 6.14 |
Gm31819 |
predicted gene, 31819 |
144 |
0.98 |
chr6_6869733_6869901 | 6.14 |
Dlx6os1 |
distal-less homeobox 6, opposite strand 1 |
1775 |
0.24 |
chrX_95658622_95659031 | 6.13 |
Zc4h2 |
zinc finger, C4H2 domain containing |
317 |
0.9 |
chr4_12287162_12287313 | 6.11 |
Gm11846 |
predicted gene 11846 |
15838 |
0.22 |
chr12_26930525_26930867 | 6.10 |
4933409F18Rik |
RIKEN cDNA 4933409F18 gene |
95823 |
0.09 |
chr3_135485492_135486205 | 6.10 |
Manba |
mannosidase, beta A, lysosomal |
223 |
0.87 |
chr2_44632627_44632778 | 6.07 |
Gtdc1 |
glycosyltransferase-like domain containing 1 |
60988 |
0.15 |
chr5_89945492_89945697 | 6.07 |
Adamts3 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 3 |
62260 |
0.14 |
chr2_125136326_125136477 | 6.05 |
Ctxn2 |
cortexin 2 |
232 |
0.88 |
chr2_146833693_146833989 | 6.04 |
Gm14114 |
predicted gene 14114 |
5891 |
0.24 |
chr8_64496502_64496653 | 6.04 |
Mir710 |
microRNA 710 |
17864 |
0.24 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 8.8 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.8 | 8.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
2.6 | 7.8 | GO:1901656 | glycoside transport(GO:1901656) |
2.1 | 6.2 | GO:0061511 | centriole elongation(GO:0061511) |
2.0 | 6.1 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
2.0 | 8.0 | GO:0007412 | axon target recognition(GO:0007412) |
2.0 | 13.9 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.9 | 5.8 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.9 | 13.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.3 | 3.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.2 | 4.7 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.2 | 5.9 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.1 | 3.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.1 | 11.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
1.1 | 3.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
1.1 | 6.4 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
1.1 | 3.2 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
1.0 | 8.3 | GO:0021860 | pyramidal neuron development(GO:0021860) |
1.0 | 3.0 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.0 | 3.0 | GO:0048880 | sensory system development(GO:0048880) |
1.0 | 4.9 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.0 | 1.0 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.9 | 4.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.9 | 4.6 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.9 | 2.6 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.9 | 3.5 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.9 | 6.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.9 | 1.7 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.8 | 2.4 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.8 | 4.8 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.8 | 3.1 | GO:0061743 | motor learning(GO:0061743) |
0.8 | 0.8 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.8 | 2.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.7 | 2.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.7 | 2.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.7 | 1.4 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.7 | 2.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.7 | 2.1 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.7 | 2.8 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.7 | 4.8 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.7 | 8.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.7 | 2.0 | GO:0021586 | pons maturation(GO:0021586) |
0.7 | 3.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.6 | 0.6 | GO:0021557 | oculomotor nerve development(GO:0021557) trochlear nerve development(GO:0021558) |
0.6 | 1.9 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.6 | 1.3 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.6 | 1.9 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.6 | 2.4 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.6 | 1.8 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.6 | 3.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.6 | 1.8 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.6 | 4.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.6 | 5.9 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.6 | 1.7 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
0.6 | 2.3 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.6 | 1.7 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.6 | 1.7 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.6 | 5.2 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.6 | 2.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.6 | 9.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.6 | 2.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.6 | 1.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.6 | 6.7 | GO:0022038 | corpus callosum development(GO:0022038) |
0.6 | 2.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.6 | 5.5 | GO:0007135 | meiosis II(GO:0007135) |
0.5 | 1.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.5 | 7.7 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.5 | 2.7 | GO:0036233 | glycine import(GO:0036233) |
0.5 | 1.6 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.5 | 1.6 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.5 | 3.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.5 | 2.6 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.5 | 5.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.5 | 1.0 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.5 | 1.5 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.5 | 1.5 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.5 | 1.5 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.5 | 2.5 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.5 | 0.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.5 | 1.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.5 | 6.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.5 | 2.7 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.5 | 1.4 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.4 | 1.8 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.4 | 1.3 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.4 | 1.3 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.4 | 1.8 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.4 | 1.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.4 | 0.4 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.4 | 1.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 2.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.4 | 0.9 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 7.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.4 | 1.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.4 | 1.7 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.4 | 1.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.4 | 1.2 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.4 | 1.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.4 | 4.0 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.4 | 2.0 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.4 | 1.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.4 | 2.4 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.4 | 1.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.4 | 0.8 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.4 | 2.7 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.4 | 1.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.4 | 1.2 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.4 | 0.8 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.4 | 1.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.4 | 0.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.4 | 0.8 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.4 | 1.1 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.4 | 2.6 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.4 | 1.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.4 | 1.1 | GO:0030070 | insulin processing(GO:0030070) |
0.4 | 8.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.4 | 1.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.4 | 0.7 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.4 | 1.5 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.4 | 0.4 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.4 | 1.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.4 | 1.1 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.4 | 1.8 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 1.4 | GO:0042737 | drug catabolic process(GO:0042737) |
0.4 | 1.4 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.3 | 5.9 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.3 | 1.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.3 | 0.3 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.3 | 2.4 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.3 | 0.7 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.3 | 0.7 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.3 | 0.7 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.3 | 1.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 0.3 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.3 | 2.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 1.0 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.3 | 0.7 | GO:0060594 | mammary gland specification(GO:0060594) |
0.3 | 1.6 | GO:0015816 | glycine transport(GO:0015816) |
0.3 | 0.6 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.3 | 2.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.3 | 0.6 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.3 | 0.6 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.3 | 3.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.3 | 0.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 0.6 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.3 | 3.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.3 | 1.8 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.3 | 1.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.3 | 2.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.3 | 0.9 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.3 | 0.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.3 | 2.3 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.3 | 8.9 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.3 | 0.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.3 | 0.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.3 | 1.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.3 | 2.3 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.3 | 0.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.3 | 2.5 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.3 | 2.0 | GO:0060539 | diaphragm development(GO:0060539) |
0.3 | 0.6 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.3 | 4.8 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 4.2 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.3 | 1.4 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.3 | 1.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.3 | 1.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.3 | 0.8 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.3 | 0.3 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
0.3 | 1.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.3 | 0.5 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.3 | 0.3 | GO:0061055 | myotome development(GO:0061055) |
0.3 | 2.1 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.3 | 1.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.3 | 0.8 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.3 | 0.8 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.3 | 1.0 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.2 | 1.7 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 1.0 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.2 | 0.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 1.5 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.2 | 0.7 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 1.2 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.2 | 2.2 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.2 | 2.9 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.2 | 0.5 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.2 | 0.7 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.2 | 0.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.2 | 1.0 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 0.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 1.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 1.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 1.7 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 0.5 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.2 | 1.9 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 1.2 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 3.7 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.2 | 1.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.9 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.2 | 0.5 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.2 | 0.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 0.9 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.2 | 0.2 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.2 | 0.9 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.2 | 0.7 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.2 | 0.2 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.2 | 0.7 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.2 | 3.5 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.2 | 1.5 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 0.7 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 0.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 1.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 1.7 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.2 | 0.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 0.6 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.2 | 0.6 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.2 | 0.6 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.2 | 3.0 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 0.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 0.4 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.2 | 0.2 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.2 | 0.6 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 0.8 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.2 | 1.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 0.4 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 1.0 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 0.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 0.6 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.2 | 0.4 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.2 | 0.8 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.2 | 2.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 0.6 | GO:0046959 | habituation(GO:0046959) |
0.2 | 2.3 | GO:0035640 | exploration behavior(GO:0035640) |
0.2 | 0.8 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.2 | 1.8 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.2 | 0.2 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 0.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.6 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.2 | 1.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 4.0 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.2 | 2.8 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.2 | 0.7 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 1.1 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 0.5 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.2 | 1.3 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.2 | 0.7 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.2 | 1.1 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.2 | 1.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.2 | 0.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 2.4 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.2 | 0.5 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 0.7 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.2 | 5.3 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.2 | 1.2 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.2 | 5.9 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.2 | 0.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 0.5 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.2 | 0.8 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.2 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 2.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 0.2 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.2 | 0.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.2 | 1.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.5 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.2 | 0.5 | GO:0035483 | gastric emptying(GO:0035483) |
0.2 | 0.2 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 0.6 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 1.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 1.4 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.2 | 1.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 0.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.2 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.2 | 0.6 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.5 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.2 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 0.8 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 0.2 | GO:0046851 | negative regulation of bone remodeling(GO:0046851) |
0.2 | 0.8 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.4 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.7 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 1.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 1.8 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 1.4 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.3 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.9 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.3 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 0.1 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.1 | 0.7 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.1 | 0.3 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.7 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.4 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.7 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.3 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.1 | 0.8 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 0.1 | GO:2001055 | positive regulation of catagen(GO:0051795) positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.1 | 7.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.4 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 0.3 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 1.1 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 9.2 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 1.7 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.7 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.1 | 0.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.6 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.4 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.1 | 1.9 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
0.1 | 0.9 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.4 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.1 | 0.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.1 | 0.6 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 1.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.1 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.1 | 0.8 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.1 | 0.2 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.2 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.6 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.1 | 1.2 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.1 | 0.2 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 1.4 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 0.6 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.3 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 1.0 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.1 | 0.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.3 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 1.0 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.3 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 3.6 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.1 | 3.9 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.1 | 0.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.3 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 0.2 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.5 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.1 | 0.1 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.1 | 0.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.1 | 0.6 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.2 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.2 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 2.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.5 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.2 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 0.5 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.1 | 1.5 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.1 | 0.6 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.3 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.1 | 1.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.7 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 2.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.6 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.1 | 0.4 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 0.1 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.1 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.2 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.7 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 0.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 1.2 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.3 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.1 | 0.2 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.8 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.3 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.1 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.1 | 2.1 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.1 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.1 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.1 | 0.7 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.1 | 0.7 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.3 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.1 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.1 | 0.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.9 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.6 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 1.6 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.1 | 0.4 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.1 | 0.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.3 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.5 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.5 | GO:0001736 | establishment of planar polarity(GO:0001736) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.9 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.2 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.1 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.5 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.3 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.1 | 0.1 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.1 | 0.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.5 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.3 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 0.1 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.1 | 0.3 | GO:0060004 | reflex(GO:0060004) |
0.1 | 0.5 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 1.0 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.7 | GO:0097178 | ruffle assembly(GO:0097178) |
0.1 | 0.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 3.5 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.1 | 0.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.4 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.3 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.3 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 1.3 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.1 | 0.2 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 1.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.3 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.4 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 3.3 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 0.1 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 0.3 | GO:0032196 | transposition(GO:0032196) |
0.1 | 0.7 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.5 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.1 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 0.2 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.1 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.1 | 0.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.3 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.1 | 0.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.1 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 0.1 | GO:0090427 | activation of meiosis(GO:0090427) |
0.1 | 0.3 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.2 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 0.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.4 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.3 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 0.2 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.1 | 0.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.1 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.1 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.1 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 2.5 | GO:0001764 | neuron migration(GO:0001764) |
0.1 | 0.9 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.1 | 0.5 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.1 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.1 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 1.9 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.2 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.0 | 0.1 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
0.0 | 0.6 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 0.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.0 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.0 | 0.0 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.0 | 0.0 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.0 | 0.0 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.0 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.0 | 0.3 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.1 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.0 | 0.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.0 | GO:0021756 | striatum development(GO:0021756) |
0.0 | 0.1 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.1 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.0 | 0.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.0 | 0.1 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.0 | 0.0 | GO:0043366 | beta selection(GO:0043366) |
0.0 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.1 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.1 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.0 | 0.1 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.0 | 0.3 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.2 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.0 | 0.0 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.0 | 0.0 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.0 | 0.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.0 | 0.0 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.0 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.0 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.0 | 0.3 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.1 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.0 | 0.1 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.0 | 0.1 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.0 | 0.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.1 | GO:0040038 | parallel actin filament bundle assembly(GO:0030046) polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
0.0 | 0.4 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.0 | 0.1 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.0 | 0.5 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.0 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 1.0 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.0 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.0 | 0.0 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.0 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.1 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.2 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.1 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.4 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.2 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.3 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.0 | 0.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.0 | 0.1 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.0 | 0.0 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.0 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.0 | 0.0 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.0 | 0.1 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.0 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:1900409 | positive regulation of cellular response to oxidative stress(GO:1900409) positive regulation of response to oxidative stress(GO:1902884) positive regulation of oxidative stress-induced cell death(GO:1903209) |
0.0 | 0.1 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.0 | 0.6 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.0 | 0.1 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.2 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.0 | 0.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.1 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.0 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.5 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.0 | 0.0 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.0 | 0.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.0 | GO:0009197 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.0 | 0.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.0 | 0.1 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.0 | 0.0 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.0 | 0.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.0 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.2 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.0 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.0 | 0.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.0 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.0 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.0 | 0.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.0 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.0 | 0.0 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.0 | 0.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.0 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.0 | 0.1 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.0 | GO:0003099 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) regulation of the force of heart contraction by chemical signal(GO:0003057) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.0 | 0.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.0 | GO:0051135 | positive regulation of NK T cell activation(GO:0051135) |
0.0 | 0.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.0 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.0 | 0.0 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.0 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 0.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.5 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.1 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.0 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.0 | 1.2 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.0 | GO:0010042 | response to manganese ion(GO:0010042) |
0.0 | 0.0 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.1 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.0 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.0 | 0.1 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.0 | 0.0 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.0 | 0.0 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.1 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.0 | 0.0 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.0 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.0 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.5 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.0 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.0 | 0.0 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.0 | 0.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.0 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.0 | 0.0 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.0 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 0.1 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.5 | GO:0070552 | BRISC complex(GO:0070552) |
1.4 | 7.2 | GO:0000235 | astral microtubule(GO:0000235) |
0.9 | 3.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.9 | 1.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.8 | 4.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.8 | 12.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.7 | 3.0 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.7 | 8.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.7 | 8.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.7 | 2.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.7 | 2.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.7 | 6.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.7 | 0.7 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.6 | 2.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.6 | 3.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.6 | 2.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.6 | 5.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.6 | 1.7 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.6 | 2.3 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.6 | 1.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.6 | 4.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.6 | 1.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.6 | 1.7 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.5 | 2.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.5 | 3.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 1.6 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.5 | 1.5 | GO:0072534 | perineuronal net(GO:0072534) |
0.5 | 1.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.5 | 3.7 | GO:0043083 | synaptic cleft(GO:0043083) |
0.5 | 3.2 | GO:0032584 | growth cone membrane(GO:0032584) |
0.4 | 0.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 3.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 1.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.4 | 1.6 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.4 | 1.9 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.4 | 0.7 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.4 | 3.2 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 5.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.3 | 2.7 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.3 | 1.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.3 | 1.3 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.3 | 1.0 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 3.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 2.1 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 0.9 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.3 | 1.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 68.5 | GO:0097060 | synaptic membrane(GO:0097060) |
0.3 | 7.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.3 | 2.7 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.3 | 1.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.3 | 0.8 | GO:0042585 | germinal vesicle(GO:0042585) |
0.3 | 2.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.3 | 0.8 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 1.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 1.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 0.7 | GO:0097441 | basilar dendrite(GO:0097441) |
0.2 | 1.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 0.7 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 1.7 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 1.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 2.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 2.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 0.9 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.2 | 2.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 2.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 0.8 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 5.6 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 0.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 1.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 0.7 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 0.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 0.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 0.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 0.5 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 1.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 15.6 | GO:0043679 | axon terminus(GO:0043679) |
0.2 | 1.9 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 1.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.7 | GO:0097433 | dense body(GO:0097433) |
0.1 | 1.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 2.8 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.0 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 2.3 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.9 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 1.1 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 0.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 1.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 2.8 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 1.6 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 3.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.3 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 2.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 2.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.8 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.5 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 1.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 2.7 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.4 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.9 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.3 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.7 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.5 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.5 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 3.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 6.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.9 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.3 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.2 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.0 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.0 | 0.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.0 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.0 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 1.0 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.0 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.0 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.0 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 0.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.0 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.0 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 0.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.0 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 12.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.8 | 8.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
2.5 | 7.6 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
2.0 | 8.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.6 | 4.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.6 | 7.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
1.4 | 4.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.2 | 5.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.2 | 3.5 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
1.1 | 3.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.1 | 3.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.0 | 6.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.0 | 3.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.0 | 2.9 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
1.0 | 3.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.9 | 5.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.8 | 7.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.8 | 9.3 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.8 | 1.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.7 | 1.4 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.7 | 2.7 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
0.6 | 2.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.6 | 5.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.6 | 4.5 | GO:0008494 | translation activator activity(GO:0008494) |
0.6 | 3.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.6 | 2.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.6 | 1.2 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.6 | 2.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.6 | 4.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.6 | 2.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.6 | 1.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.6 | 1.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.5 | 1.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.5 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.5 | 1.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.5 | 2.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.5 | 1.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.4 | 1.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.4 | 1.8 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.4 | 3.1 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.4 | 2.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.4 | 1.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.4 | 1.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.4 | 1.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.4 | 1.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.4 | 2.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.4 | 1.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 6.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.4 | 2.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.3 | 2.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 1.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 1.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 1.3 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 1.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.3 | 1.0 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 6.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 0.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.3 | 1.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 0.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 0.9 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.3 | 0.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 1.2 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.3 | 0.9 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.3 | 1.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.3 | 0.9 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 6.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 2.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.3 | 1.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 1.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 2.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.3 | 1.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 0.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 3.9 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.3 | 1.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.3 | 2.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 0.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 0.8 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 1.5 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.3 | 2.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.3 | 0.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.3 | 5.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.7 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.2 | 5.2 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 0.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 4.4 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.2 | 0.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 2.5 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.2 | 1.8 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.2 | 1.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 2.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 2.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 0.2 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.2 | 1.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.6 | GO:0052623 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.2 | 0.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 0.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 1.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 0.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 3.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 1.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 2.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.2 | 1.2 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.2 | 1.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.6 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 1.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.6 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 1.8 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 1.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 0.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 0.5 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.2 | 0.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 0.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 0.7 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.2 | 0.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 0.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 1.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 1.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 0.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 0.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 2.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 0.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 0.9 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 1.1 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.3 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.7 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 1.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.8 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 2.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 1.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.5 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 1.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.6 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 0.5 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.4 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.1 | 3.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.3 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 3.9 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.3 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.9 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 1.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 1.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 2.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.4 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 1.2 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 1.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.6 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.1 | 0.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 1.0 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.3 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 0.9 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 1.0 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.3 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 1.4 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 2.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 1.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 1.0 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.1 | 0.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.2 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.2 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.5 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.1 | 0.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 2.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 2.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.6 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 5.5 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 3.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 3.4 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.4 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 2.5 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.6 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 1.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.1 | 0.2 | GO:0001032 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 1.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.2 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.0 | 0.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 1.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.3 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.6 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.0 | 0.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 1.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.0 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.0 | 1.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.0 | 0.2 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.0 | 0.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 1.0 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.0 | 0.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 1.0 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 0.1 | GO:0052759 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.0 | 0.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.0 | 0.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.8 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.4 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.1 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.0 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.0 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.0 | 0.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 2.1 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 0.1 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.3 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.0 | 1.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.5 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.8 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.1 | GO:0034838 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 15.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 10.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 6.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 0.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 0.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 0.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 7.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 8.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 3.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 6.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 2.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 0.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 2.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 3.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 5.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 2.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 3.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 4.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 5.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 1.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.3 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.0 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.4 | 12.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.4 | 4.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.4 | 6.3 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.4 | 3.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.4 | 0.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 8.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 5.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.3 | 9.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 6.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 1.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.3 | 2.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 7.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 0.8 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 2.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 0.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 1.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.2 | 2.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 2.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 3.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 1.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 2.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 2.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 1.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 1.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 5.3 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.2 | 1.8 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.2 | 2.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 0.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 1.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 2.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.9 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 1.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 2.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 1.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.3 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 1.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 1.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 3.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.9 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 1.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 1.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 3.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.4 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 1.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 2.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.7 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 2.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 2.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.1 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
0.0 | 0.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 1.2 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.0 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.0 | 0.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |